Eversight Academy webinar | Antibody-drug conjugates and the ocular surface

Online

Presenter: Asim V. Farooq, MD Date: 7:30 p.m. ET Thursday, Dec. 5 Antibody-drug conjugates (ADCs) are a new and growing class of targeted cancer drugs. These drugs commonly cause ocular surface toxicity. This webinar will review what is currently known about ADC-associated ocular surface toxicity and how cornea specialists should approach these patients. Register today

In this season of gratitude, Eversight has launched a matching

#GivingTuesday

campaign to impact even more lives. Please consider supporting Eversight and help us earn a generous $4,000 match from our Board of Directors.
GIVE TODAY
close-link

Stay in touch

Help us tailor your Eversight experience by subscribing to information that is meaningful to you.
Subscribe now
close-link